Cargando…
Development of Drug-Induced Inverse Psoriasis in a Patient with Crohn’s Disease
Crohn’s disease is difficult to manage and often requires multiple medications. While these drugs vastly improve quality of life, physicians must monitor for adverse events. We report a case of a flare of inverse psoriasis after 15 months of treatment with ustekinumab. This is the third reported cas...
Autores principales: | Darwin, Evan, Deshpande, Amar, Lev-Tov, Hadar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Gastroenterology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013682/ https://www.ncbi.nlm.nih.gov/pubmed/29951562 http://dx.doi.org/10.14309/crj.2018.47 |
Ejemplares similares
-
A Case Report of a Patient with Turner Syndrome, Multiple Comorbidities, and Pustular Psoriasis: Correlation or Coincidence?
por: Egger, Andjela, et al.
Publicado: (2020) -
Infliximab-induced intertriginous psoriasis in patient with Crohn's disease
por: Mola, Federica, et al.
Publicado: (2011) -
Ustekinumab for Successful Treatment of Refractory Esophageal Crohn’s Disease
por: Barkin, Jodie A., et al.
Publicado: (2016) -
Psoriasis paradox—infliximab-induced psoriasis in a patient with Crohn’s disease: a case report and mini-review
por: Mohammed, Reem Hamdy A, et al.
Publicado: (2023) -
Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
por: Matsumoto, Satohiro, et al.
Publicado: (2018)